Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?

Slides:



Advertisements
Similar presentations
Jessica Price Advanced Cell and Molecular Biology Lake Forest College
Advertisements

Using Gene Knockout and Transgenic Approaches to Evaluate in vivo Functions of CNS Regeneration Inhibitors: How Important is Nogo ? David Mann Tammy Hibler.
Comparing the Toxicity of Zinc Deficient Superoxide Dismutase (SOD) and the Quad SOD mutant: Implications for Amyotrophic Lateral Sclerosis Jesse Fitzpatrick.
Α-Synuclein Interaction with Phospholipids: Possible Implications for Parkinson’s Disease Literature Seminar by Jessica L. Anderson.
An Investigation of the Interactions Between Zinc-deficient and Copper, Zinc Superoxide Dismutase Katie Meyers Dr. Joe Beckman Department of Biochemistry/Biophysics.
Do oligomers damage membranes?. Oligomers bind to vesicle membranes (in vitro incubation with ex-vivo or artificial lipids) Brain derived lipids Phosphatidylglycerol.
Zinc-deficient SOD in ALS Emily Clark Dr. Joe Beckman Department of Biochemistry/Biophysics.
Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical.
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures.
Corso di Terapia genica Prof.ssa Saggio a.a. 2011/2012 LRRK2-FAMILIAR PARKINSON DISEASE: POSSIBLE APPROACH OF GENE THERAPY Cesario Claudia Giusti Valentina.
Tasha A. Desai, Dmitry A. Rodionov, Mikhail S. Gelfand, Eric J. Alm, and Christopher V. Rao 1 Alvin Chen April 14, 2010.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
Construction, Transformation, and Prokaryote Expression of a Fused GFP and Mutant Human IL-13 Gene Sequence Lindsay Venditti, Department of Biological.
Manufacture of Human Interleukin 13 Protein Using a Prokaryotic Expression System Ryan Rupp, York College of Pennsylvania, Department of Biological Sciences.
The Importance of Non-conserved Regions in Protein Remodeling by the E. coli Molecular Chaperone, ClpB Zakiya Qualls.
DNA Methylation in Histone H3.3 Lysine to Methionine Mutants Ellie Degen with Stefan Lundgren, Siddhant Jain and Dr. Peter W. Lewis UW Department of Biomolecular.
A carboxylated Zn-phthalocyanine inhibits the fibril formation of Alzheimer’s amyloid β peptide Atsushi Nagai Dept. Laboratory Medicine Shimane University.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Phosphorylation of the Tomato Β-Subunit of the SnRK Complex by Adi3 and its Possible Role in Sugar Signaling JULIAN AVILA-PACHECO.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
LOGO Isolation and characterization of regulators of oxidative stress induced apoptosis in yeast Yaron Fireizen, Christine Crozier and Julie Anderson Biology.
Determining if the fused product of Botox A and GFP can be used to observe the binding patterns of Botulinum toxin A. Felicia Yothers Department of Biological.
Advances in polyglutamine disease research & therapy
Taylor Bundy Advisor: Dr. Ryan Mehl, Associate Professor of Biochemistry Determining the structural effects of Hsp90 nitration on protein interactions.
Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.
Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
Genomic Screening Princess Kara Parker-Smith Marlyn Gonzalez and Dr. Peter Lipke Hunter College, CUNY Harlem Children Society.
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Yeast Lab 2 To do today: 1.Make lysates of WT, sec18 & sec61 strains grown at RT & 37°C. 2.Run lysates on 12% SDS- PAGE gel. 3.Score results from yeast.
Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.
Structures and functions of biomolecules & applications Purin Charoensuksai, PhD Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University.
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Da-Hyeong Cho Protein Engineering Laboratory Department of Biotechnology and Bioengineering Sungkyunkwan University Site-Directed Mutagenesis.
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Danny Rayes.
CLINICAL CORRELATIONS
Figure 1. RP2 possesses potential sites for N-terminal acylation
Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Danny Rayes.
Protein conformational disorders
CLINICAL CORRELATIONS
Protein conformational disorders
Advisor: Shubhik K. DebBurman Department of Biology
Addressing the role G1 phase length on genetic instability in S
Neurodegeneration caused by prions. A
The distribution and function of the Adenovirus L4-33K protein
Alpha-synuclein in Parkinson's disease
Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein by Xiang Yu, Todd L. Mollan, Andrew Butler, Andrew.
Cold Adaptation in Budding Yeast
David Mann Tammy Hibler Isaac Holmes Arun George Paul
CLINICAL CORRELATIONS
STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity
Phosphorylation of a tyrosine residue in mGluR1a-CT1 by Fyn.
Parkinson's Disease Neuron
Multiple PKCδ Tyrosine Residues Are Required for PKCδ-Dependent Activation of Involucrin Expression—a Key Role of PKCδ-Y311  Ling Zhu, Chaya Brodie, Sivaprakasam.
RRNA Modifications in an Intersubunit Bridge of the Ribosome Strongly Affect Both Ribosome Biogenesis and Activity  Xue-hai Liang, Qing Liu, Maurille.
Profilaggrin Requires both Linker and Filaggrin Peptide Sequences to Form Granules: Implications for Profilaggrin Processing In Vivo1  Melanie K. Kuechle,
Volume 17, Issue 1, Pages (January 2005)
Volume 34, Issue 4, Pages (May 2009)
Together, PKS5 and SCaBP1 Inhibit the Activity of the PM H+-ATPase AHA2 When Expressed in Yeast by Reducing the Amount of Protein Bound.(A) Drop.
Volume 14, Issue 2, Pages (August 2008)
Volume 38, Issue 3, Pages (May 2003)
Vidhya Ramachandran, Khyati H. Shah, Paul K. Herman  Molecular Cell 
Volume 5, Issue 6, Pages (June 2000)
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress  Benjamin Guy Trist, Dominic.
Volume 85, Issue 1, Pages (January 2015)
Presentation transcript:

Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?

Parkinson’s Disease  -Synuclein Misfolding Model System & Hypothesis Results Conclusion Road Map

Parkinson’s Disease Alzheimer’s Disease Huntington’s Disease Prion Disease Spinocerebellar Ataxia  -Synuclein Amyloid  -peptide Huntingtin Prion protein Ataxin Disease Protein Protein Misfolding Cell Death Neurodegeneration

Parkinson’s Disease Affects over 4 million people worldwide Slowness of movement, resting tremors, postural instability Death of dopaminergic neurons that control movement Protein aggregates within these neurons DiseasedHealthy Perves et al. Neuroscience, 2nd edition

 -Synuclein  synuclein Functions Unknown 140 amino acids Presynaptic Terminals of neurons Cytoplasmic Protein

 -Synuclein Misfolding & Toxicity Native  -SynucleinMisfolded  -Synuclein Aggregated  -Synuclein (Lewy Bodies) Toxicity (Cell Death) Spillantini et al., 1997

 -syn Wild-type A30P A53T A30P/A53T  -syn Natural Mutations -Genetic PD Artificial Mutation Known Familial PD Mutants Normal Gene -In all humans  -syn E46K Newly Discovered, 2004

S. cerevisiae Prion disease model (1998) HD model (1999) PD model (2003) Budding Yeast Model System Why Yeast? 1. Conservation of genes 2. Sequenced Genome

DebBurman Yeast Model 19 kDa 62 kDa54 kDa 28 kDa  -synGFP  -syn PredictionsOur Model In our model  -synuclein runs 8-10 kDa higher on protein gels. What causes this altered migration of  -synuclein? Johnson, 2003 Sharma, 2004

Systematic Examination of Possible  - Synuclein Modifications Phosphorylation Glycosylation Lipidation Ubiquitination Nitrosylation Oxidation Post-Translational Modifications

Post-Translational Modification -Lee, et al. 2000, demonstrated that  -synuclein was nitrated in Lewy Bodies. -Souza, et al. 2000, demonstrated that nitrating and oxidizing agents can nitrate and oxidize  -synuclein at tyrosine residues, resulting in oligomers -Fujiwara, et al. 2003, showed that  -synuclein can be phosphorylation at Serine 129. This promotes fibril formation.

Creation of Post-Translational Modification Mutants GFP Y125F Y39F Y133F S87A S129A  -Synuclein Mutants Created Seen in PD Patients  Nitrosylation  Oxidation  Phosphorylation  Ubiquitination  Glycosylation sites unknown

Two Stories Chapter 1: Characterizing The Newly Discovered E46K Mutant Chapter 2: Role of Post-Translational Modifications in  - Synuclein

E46K: Hypotheses and Aims 1. Expression of E46K  -synuclein will misfold, aggregate, and be toxic to yeast. 2. Express wild-type and familial mutant E46K  -synuclein in S. cerevisiae yeast model. 3. Evaluate cellular localization and toxicity of wild-type versus E46K familial mutant form of  -synuclein expressed in S. cerevisiae. 1. Construct E46K mutant Hypothesis Aims

Site-Directed Mutagenesis Methylated plasmid -Glu residues were mutated to Lys (E K) MethylationMutagenesis Mutated plasmid X X X X Transformation into E. Coli X Primers: 1 contains target mutation WT gene Aim 1: Construction of E46K Mutant

Western Analysis Transfer Proteins Heat to separate proteins Incubate Blot with Anti-bodies Development of Blot Visualization of Proteins Aim 2: Expression of E46K Mutant

Aim 2: Expression of E46K Western Analysis ~34kDa GFP MW Marker E46K ~124 kDa ~62 kDa -E46K  -synuclein will have SDS insoluble aggregates -Dimer formation of E46K  -synuclein will be visualized Predictions

GFP Wt Syn-GFP Y39F Syn-GFP Y125F Syn-GFP E46K Syn-GFP S129A Syn-GFP ~62kDa MW kDa ~34kDa Syn GFP — ——— Wt Syn-GFP A53T Syn-GFP Db Syn-GFP + — A30P Syn-GFP ~28kDa ~34kDa ~62kDa + Western Blot Results: Expression of Familial Mutant E46K -E46K runs 8-10 kDa higher than predicted -Lack of SDS insoluble aggregates Coomassie Stain Sharma, 2004.

Optical Density and Spotting Growth Analyses Familial mutant  -synuclein will be toxic to yeast cells E46K mutant  -synuclein will be the most toxic to yeast cells Wild-type  -synuclein will not be toxic to yeast cells Predictions Aim 3: Examining Toxicity of  - Synuclein

Time (hours) Log Cell Concentration Results: E46K Mutant  -Synuclein Expression Is Toxic To Yeast E46K expressing cells show a major lag in growth Growth Curve

Results: E46K Mutant  -Synuclein Expression Is Toxic To Yeast 5X Less Spotting Glucose (non-inducing) Galactose (inducing) Parent Vector GFP E46K A30P A53T WT E46K expressing cells show no major decrease in growth rates

Aim 3: Localization of E46K Live Cell GFP Microscopy E46K-GFP(CT) -E46K  -synuclein expression= foci formation -Localization to plasma membrane Predictions

E46K-GFP A30P/A53T-GFPA53T-GFP A30P-GFP Wt-GFP Results:  -Synuclein Localizes to the Periphery & Forms Foci Live Cell GFP Microscopy - Halos are preserved -E46K shows increase foci formation compared to other familial mutants

Wild-type  - Synuclein Misfolded E46K  - Synuclein Toxicity No Toxicity  -Synuclein Folding Live Cell Microscopy Toxicity  -Synuclein Misfolding & Aggregation In vivo Increased Foci Formation

Chapter 2 Role of Post-Translational Modifications in  -Synuclein

Post-Translational: Hypotheses & Aims 1. Post-translational modifications of  -synuclein will decrease its misfolding and aggregation. 2. Expression of post-translational mutant  -synuclein will not be toxic to yeast. Hypothesis Aims 1. Construct post-translational S129A, Y39F, and Y125 mutants 2. Express wild-type and mutant S129A, Y39F, and Y125  -synuclein in S. cerevisiae yeast model. 3. Evaluate cellular localization and toxicity of wild-type versus mutant forms of  -synuclein expressed in S. cerevisiae.

Aim 2: Expression of  -Synuclein Western Analysis ~34kDa GFP MW Marker ~54 kDa WT S129A Y125F Y39F ~62 kDa -Post-translational mutants will migrate at lower molecular weights -WT  -synuclein will run at ~62 kDa -Protein expression will be equal in all lanes Predictions

GFP Wt Syn-GFP Y39F Syn-GFP Y125F Syn-GFP S129A Syn-GFP ~62 kDa MW kDa ~34kDa Western Blot Results:  -Synuclein Expression of S129A, Y39F, and Y125F Mutants Coomassie Stain -Surprisingly post-translational mutants run 8-10 kDa higher than predicted -Lack of SDS insoluble aggregates

Optical Density and Spotting: Growth Analysis S129A, Y39F, & Y125F mutant  -synuclein will not be toxic to yeast cells Wild-type  -synuclein will not be toxic to yeast cells Aim 3: Examining Toxicity of  - Synuclein Predictions

Results: S129A, Y39F, and Y125F Mutant  - Synuclein Expression Is Toxic To Yeast Log Cell Concentration Time (hours) Growth Curve - Post-translational mutants show major growth deficiencies

 -Synuclein Expression of S129A, Y39F, and Y125F mutants Non-inducing Inducing Parent Vector GFP Y39F Y125F S129A WT Spotting - Post-translational mutants show minor growth deficiencies

Aim 3: Localization of  -Synuclein Mutants Live Cell GFP Microscopy S129A-GFP(CT) Y39F-GFP(CT)Y125F-GFP(CT) -Post-translational mutant  -synuclein will localize to plasma membrane Predictions

S129A-GFPY125F-GFPY39F-GFP GFP Wt-GFP Results: S129A, Y39F, and Y125F Mutant  - Synuclein Localizes Near Yeast Plasma Membranes Live Cell GFP Microscopy - Halos are preserved -Post-translational modifications show lack of foci formation

Conclusions 1. Familial E46K mutant  -synuclein induces toxicity upon expression 2. Increased foci formation with E46K  -synuclein expression 3.  -Synuclein’s increased size in not due to phosphorylation at Serine 129 and nitrosylation at Tyrosines 39 and S129A, Y39F, and Y125F mutant  -synuclein showed unexpected increase in toxicity 5. In vivo membrane association of S129A, Y39F, and Y125F  -synuclein

Discussion E46K Toxicity May Be Related To Increased Misfolding Zarranz, et al., 2004: Study showed that E46K  -syn is more prone to aggregation compared to other familial mutants E46K had extensive peripheral localization and increased foci formation compared to other  -syn expressing cells Increased aggregation of E46K  -syn may increase its toxicity = cell death OD600 showed that E46K cells have large lag in growth; spotting assays show no inhibited growth rate.

Discussion Increased Size: Not Due to Phosphorylation or Nitrosylation DebBurman yeast model:  -syn ran ~8-10 kDa higher  -Syn migrated higher than predicted due to post-translation modifications on Ser129 & Tyr 39 and 125 No change in migration patterns of  -syn deficient for these residues Increased size not due to phosphorylation or nitrosylation Increased size maybe due to other modifications

Discussion Post-translational Mutants Showed Unexpected Increase In Toxicity Giasson, et al., 2002: nitrosylation and phosphorylation modifications may be responsible for inclusions seen in PD patients Formation of inclusions coincides with disease onset We expected to see less toxicity when key sites are mutated Phosphorylation or nitrosylation modifications maybe beneficial to  -syn expressing cells

Discussion In vivo membrane association of S129A, Y39F, and Y125F  -Synuclein DebBurman yeast model: Peripheral localization of wild-type  -syn Post-Translational mutant  -syn localized to yeast plasma membrane  -Syn contains a motif that has the ability to bind phospholipids vesicles The cytoplasm of yeast cells is smaller than those in neurons;  -syn may have easier ability to bind to membranes

Future Studies 1. Examine other  -synuclein residues linked to nitrosylation and phosphorylation sites. 2. Examine other post-translational modification sites linked to  -synuclein misfolding. 3. Assessment of stability of mutant forms of  -synuclein in S. cerevisiae.

Acknowledgements DebBurman Lab Dr. Shubhik DebBurman Isaac Holmes Nijee Sharma Katrina Brandis Ruja Shrestha Lavinia Sintean Tasneem Saylawala Arun George Paul Jessica Price NIH NSF